Journal of Inorganic Materials

• Research Paper • Previous Articles     Next Articles

Preparation and Hemostatic Properties of Mesoporous Silica-based Xerogels

LI Xiao-Sheng1, LIU Chang-Sheng1, YUAN Yuan1, WANG Li-Jun2, WANG Qiu-Yun2   

  1. 1. Key Laboratory for Ultrafine Materials of the Ministry of Education, Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, China; 2. Department of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2007-02-13 Revised:2007-07-11 Published:2008-03-20 Online:2008-03-20

Abstract: A biodegradable silica-based xerogel with nano-scale mesopores was synthesized by using improved sol-gel process, and its hemostatic properties were investigated. The phase state, chemical structure, surface morphology, specific surface areas and mesoporous structure of the synthesized silica-based xerogels were measured systemically by means of X-ray diffraction (XRD), infrared spectrum (FTIR), transmission electron microscope (TEM), and N2 adsoption-desoption (BET) techniques, respectively. The effects of the silica-based xerogel on intrinsic and extrinsic blood clotting systems were examined through the activated partial thromboplastin time (APTT) and prothrombin time (PT) tests in ~vitro, respectively. The hemostatic performance of the prepared silica-based xerogel was evaluated at the rabbit’s ear side veins compared with a traditional hemostatic dressing (Yunnan Baiyao). The results reveal that the non-crystalline silica-based xerogel with 901.17m2/g specific surface areas and 3.255nm in apertures is obtained after calcining at 600℃. The silica-based xerogel facilitates both of the intrinsic and extrinsic clotting activities significantly. The silica-based xerogel has good hemostatic effect on the rabbit’s ear side veins which is better than that of the Yunnan Baiyao.

Key words: silica-based xerogel, mesopore, specific surface area, hemostasis

CLC Number: